In Reply to Dr. Lambein et al “HER2 protein overexpression in non‐amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?”
This article is protected by copyright. All rights reserved.
Source: Histopathology - Category: Pathology Authors: Yihong Wang,
Yiang Hui,
Murray B. Resnick Tags: Correspondence Source Type: research
More News: Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | HER2 | Pathology